ID   AHH-1
AC   CVCL_3640
SY   AHH1
DR   BTO; BTO:0006377
DR   CLO; CLO_0001688
DR   ATCC; CRL-8146
DR   BioSample; SAMN03471195
DR   Wikidata; Q54748905
RX   Patent=US4532204;
RX   PubMed=2307151;
RX   PubMed=8236284;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8146.
CC   Population: Caucasian.
CC   Doubling time: 16-19 hours (PubMed=8236284).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 10
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2710 ! RPMI-1788
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
RX   Patent=US4532204;
RA   Crespi C.L., Thilly W.G.;
RT   "Mutation assays involving blood cells that metabolize toxic
RT   substances.";
RL   Patent number US4532204, 30-Jul-1985.
//
RX   PubMed=2307151; DOI=10.1002/em.2850150203;
RA   Crespi C.L., Seixas G.M., Turner T., Penman B.W.;
RT   "Sodium fluoride is a less efficient human cell mutagen at low
RT   concentrations.";
RL   Environ. Mol. Mutagen. 15:71-77(1990).
//
RX   PubMed=8236284; DOI=10.1016/0300-483X(93)90062-W;
RA   Crespi C.L., Langenbach R., Penman B.W.;
RT   "Human cell lines, derived from AHH-1 TK+/- human lymphoblasts,
RT   genetically engineered for expression of cytochromes P450.";
RL   Toxicology 82:89-104(1993).
//